CO5070569A1 - COMPOUND OF AMINOAZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM - Google Patents

COMPOUND OF AMINOAZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM

Info

Publication number
CO5070569A1
CO5070569A1 CO99031508A CO99031508A CO5070569A1 CO 5070569 A1 CO5070569 A1 CO 5070569A1 CO 99031508 A CO99031508 A CO 99031508A CO 99031508 A CO99031508 A CO 99031508A CO 5070569 A1 CO5070569 A1 CO 5070569A1
Authority
CO
Colombia
Prior art keywords
compound
aminoazol
pharmaceutically acceptable
acceptable salt
same
Prior art date
Application number
CO99031508A
Other languages
Spanish (es)
Inventor
Peter Buhlmayer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO5070569A1 publication Critical patent/CO5070569A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con un compuesto de la fórmula (I):<EMI FILE="99031508_1" ID="1" IMF=JPEG >o una sal de el mismo, métodos para su preparación y composiciones farmacéuticas que los contienen.The present invention relates to a compound of the formula (I): <EMI FILE = "99031508_1" ID = "1" IMF = JPEG> or a salt thereof, methods for its preparation and pharmaceutical compositions containing them.

CO99031508A 1998-05-29 1999-05-21 COMPOUND OF AMINOAZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM CO5070569A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1998124175 DE19824175A1 (en) 1998-05-29 1998-05-29 Amino azole compounds

Publications (1)

Publication Number Publication Date
CO5070569A1 true CO5070569A1 (en) 2001-08-28

Family

ID=7869385

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99031508A CO5070569A1 (en) 1998-05-29 1999-05-21 COMPOUND OF AMINOAZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM

Country Status (4)

Country Link
AU (1) AU4501699A (en)
CO (1) CO5070569A1 (en)
DE (1) DE19824175A1 (en)
WO (1) WO1999062892A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE314371T1 (en) 1998-11-10 2006-01-15 Merck & Co Inc SPIRO-INDOLE AS Y5 RECEPTOR ANTAGONISTS
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
DE60034783T2 (en) * 1999-04-22 2008-01-31 H. Lundbeck A/S, Valby SELECTIVE NPY (Y5) ANTAGONISTS
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
WO2001017995A1 (en) 1999-09-10 2001-03-15 Merck & Co., Inc. Tyrosine kinase inhibitors
WO2001064675A1 (en) * 2000-03-03 2001-09-07 Novartis Ag Condensed thiazolamines and their use as neuropeptide y5 antagonists
AU2002346053B2 (en) 2001-06-22 2008-03-13 Merck & Co., Inc. Tyrosine kinase inhibitors
US20050107411A1 (en) * 2001-12-17 2005-05-19 Macneil Douglas J. Method for treating circadian rhythm disruptions
EP1480976B1 (en) 2002-02-28 2007-09-19 F.Hoffmann-La Roche Ag Thiazole derivatives as npy receptor antagonists
US6872724B2 (en) 2002-07-24 2005-03-29 Merck & Co., Inc. Polymorphs with tyrosine kinase activity
AU2003253364B2 (en) * 2002-08-07 2007-06-07 F. Hoffmann-La Roche Ag Thiazole derivatives
MXPA06001570A (en) * 2003-08-12 2006-05-15 Hoffmann La Roche 2-amino-5-benzoylthiazole npy antagonists.
KR20060037436A (en) 2003-08-12 2006-05-03 에프. 호프만-라 로슈 아게 Thiazole derivatives as npy antagonists
AR081331A1 (en) 2010-04-23 2012-08-08 Cytokinetics Inc AMINO- PYRIMIDINES COMPOSITIONS OF THE SAME AND METHODS FOR THE USE OF THE SAME
WO2011133920A1 (en) 2010-04-23 2011-10-27 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081626A1 (en) 2010-04-23 2012-10-10 Cytokinetics Inc AMINO-PYRIDAZINIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT CARDIAC AND SKELETIC MUSCULAR DISORDERS
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4326465A1 (en) * 1993-01-20 1995-02-09 Thomae Gmbh Dr K Amino acid derivatives, pharmaceutical compositions containing these compounds and process for their preparation
DE19544687A1 (en) * 1995-11-30 1997-06-05 Thomae Gmbh Dr K Amino acid derivatives, medicaments containing these compounds and processes for their preparation
AU7692696A (en) * 1995-12-01 1997-06-27 Novartis Ag Heteroaryl derivatives
TW399051B (en) * 1996-01-31 2000-07-21 Ssp Co Ltd A novel benzoazine thiazolidinedione derivative and pharmaceutical composition for reducing blood glucose
EP0968209A1 (en) * 1997-01-28 2000-01-05 Merck & Co., Inc. THIAZOLE BENZENESULFONAMIDES AS $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives

Also Published As

Publication number Publication date
DE19824175A1 (en) 1999-12-02
WO1999062892A1 (en) 1999-12-09
AU4501699A (en) 1999-12-20

Similar Documents

Publication Publication Date Title
CO5070569A1 (en) COMPOUND OF AMINOAZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM
AR037517A1 (en) DERIVATIVES OF NAFTIRIDINES, A PROCESS FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AN INFLAMMATORY DISEASE
MX9204268A (en) A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME.
CO4290417A1 (en) NEW BENZOYLGUANIDINES AS MEDICINES AND THEIR PREPARATION.
CO5180581A1 (en) COMPOUNDS FOR THE TREATMENT OF THE ISCHEMIA PHARMACEUTICAL TIONS THAT CONTAIN THEM FOR THE TREATMENT OF THE ISCHEMIA
AR066982A2 (en) HETEROAROMATIC COMPOUNDS REPLACED AS INHIBIDORESS TIROSIN QUINASA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF MEDICINES
CO5280060A1 (en) BICYCLE AMINO ACIDS AS PHARMACEUTICAL AGENTS
AR004700A1 (en) 1ALFA, 26 DIHIDROXI-D-HOMO-VITAMIN D3, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCEDURE FOR ITS PREPARATION AND USE OF THEM IN THE ELABORATION OF A MEDICINAL PRODUCT
MX9204354A (en) HETERO-CYCLE COMPOUNDS OF 5 MEMBERS, PROCEDURE TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
AR022008A1 (en) A COMPOSITION OF CONTROLLED GALANTAMINE RELEASE, A PROCESS FOR THE PREPARATION OF THE SAME, AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
CO4940450A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING VORICONAZOLE
SE9504661D0 (en) New compounds
AR034120A1 (en) HALOGENATED DERIVATIVE COMPOUND OF HEPTENOIC ACID 2-AMINO-4,5, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND THE USE OF SUCH COMPOUND AND SUCH COMPOSITION IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO INHIBIT OR MODULATE NITRIC ACID SYNTHESIS
AR025052A1 (en) DERIVATIVES OF 2-DIALQUILAMINOALQUILBIFENILO SUBSTITUTED, PROCEDURE FOR PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS AND THE USE OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES.
MX9202544A (en) SUBSTITUTED AND ANALOGUE DIAMINOPHALIMIDES COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
FI972434A0 (en) Pharmaceutical composition containing lamotrigine
PT1233953E (en) NEW BENZOTIADIAZIN DERIVATIVES PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
DE69315699D1 (en) INHIBITORS AGAINST AGGREGATION OF BLOOD PLATES
ES2194933T3 (en) INHIBITORS OF THE PLAQUETARY AGGREGATION.
IS1664B (en) New method of producing substituted 4-phenyl-4-piperidinecarboxamide which has both local anesthetic and analgesic effect
AU611113B2 (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
PE45195A1 (en) DERIVATIVE OF AMINO ACID, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT
MX9400165A (en) DERIVATIVES OF TER-BUTYLERGOLINE, PROCESS FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IT9019793A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE